Second quarter revenue grew 7% year-over-year to $4.6B, with record operating cash flow and strong adjusted EBITDA margin. Guidance for 2026 was raised across revenue, EPS, and cash flow, driven by robust defense and homeland performance, while health segment adapts to VA incentive changes.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.